Trial Profile
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Feb 2024
Price :
$35
*
At a glance
- Drugs Clotrimazole (Primary)
- Indications Otomycosis
- Focus Therapeutic Use
- Acronyms CLEAR-2
- Sponsors SALVAT
- 03 Aug 2022 Status changed from active, no longer recruiting to completed.
- 28 Sep 2021 Status changed from recruiting to active, no longer recruiting.
- 16 Mar 2021 Planned End Date changed from 1 Jul 2021 to 1 Nov 2021.